Nuclear medicine has transformed dramatically from a marginal diagnostic field into a crucial component of modern healthcare. Historically limited to gamma camera imaging and basic therapies, it is now a central player in oncology and other medical disciplines due to advancements in imaging technology, new radiopharmaceuticals, and a deeper understanding of diseases. The European Association of Nuclear Medicine (EANM) has been instrumental in these developments, promoting standardization and education while also addressing challenges like regulatory complexities and workforce shortages. Innovations such as personalized dosimetry and the integration of artificial intelligence are enhancing patient outcomes and decision-making processes. As demand for nuclear medicine grows, expected to increase five-fold in the next 15 years, there is a push for better collaborations within the healthcare industry and a more significant integration into core clinical practices.
Mon, 10 Aug 2026 14:30:13 GMT | Innovation News Network